Russell Investments Group
AMLX icon

Russell Investments Group’s Amylyx Pharmaceuticals AMLX Stock Holding History

Russell Investments Group’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.57M Buy
87,574
+28,228
+48% +$437K ﹤0.01% 2220
2026
Q1 		$825K Sell
59,346
-6,092
-9% -$85.7K ﹤0.01% 2308
2025
Q4 		$790K Buy
65,438
+10,032
+18% +$136K ﹤0.01% 2325
2025
Q3 		$753K Buy
55,406
+49,177
+789% +$463K ﹤0.01% 2306
2025
Q2 		$39.9K Sell
6,229
-471
-7% -$2.29K ﹤0.01% 3035
2025
Q1 		$23.7K Buy
6,700
+1,631
+32% +$5.8K ﹤0.01% 3071
2024
Q4 		$19.2K Sell
5,069
-1,920
-27% -$9.04K ﹤0.01% 3015
2024
Q3 		$22.6K Sell
6,989
-2,130
-23% -$4.79K ﹤0.01% 2934
2024
Q2 		$17.3K Buy
9,119
+8,957
+5,529% +$17.4K ﹤0.01% 2967
2024
Q1 		$460 Sell
162
-2,675
-94% -$35K ﹤0.01% 3216
2023
Q4 		$41.8K Sell
2,837
-1,646
-37% -$25.2K ﹤0.01% 2653
2023
Q3 		$82.1K Buy
4,483
+4,289
+2,211% +$90.7K ﹤0.01% 2661
2023
Q2 		$4.18K Buy
194
+162
+506% +$4.38K ﹤0.01% 3143
2023
Q1 		$939 Buy
+32
New +$1.11K ﹤0.01% 3052

Other funds holding AMLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
IGAM
iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

Russell Investments Group's AMLX Position: Q2 2026 in Review

Russell Investments Group increased its Amylyx Pharmaceuticals (AMLX) stake by 48% in Q2 2026, buying an estimated $437K and bringing the position to 87,574 shares worth $1.57M. The position accounts for ﹤0.01% of the portfolio, ranked #2220.

Russell Investments Group first reported a position in AMLX in Q1 2023 and has held it in 14 quarters since. 59 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • Russell Investments Group held 87,574 shares of Amylyx Pharmaceuticals worth $1.57M as of Q2 2026.
  • Russell Investments Group bought 28,228 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $437K.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2220 holding.
  • Russell Investments Group first reported a position in Amylyx Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
  • 59 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.